Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.61
- +0.02+0.56%
Market Closed Dec 20 15:00 CST
2.57BMarket Cap-156.96P/E (TTM)
3.62High3.57Low319.15KlotVolume3.58Open3.59Pre Close114.65MTurnover4.48%Turnover RatioLossP/E (Static)712.84MShares4.3852wk High4.55P/B2.57BFloat Cap2.2152wk Low3.95Limit Up712.84MShs Float22.10Historical High3.23Limit Down1.39%Amplitude2.21Historical Low--Dividend TTM3.59Avg Price171.49KlotAsk--Div YieldTTM100Lot Size147.38KlotBid
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Notice on holding the first bondholders\' meeting in 2024
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: Zhejiang Asia Pacific Pharmaceutical Co., Ltd. publicly issued convertible corporate bonds tracking rating report
Asia Pacific Pharmaceuticals: Convertible Corporate Bonds 2022 Interest Payment Notice
Asia Pacific Pharmaceuticals: 2021 Interest Payment Announcement on Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: 2020 Interest Payment Announcement on Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: New Century Ratings Announcement on Adjusting the Company's Rating Outlook
Asia Pacific Pharmaceuticals: Announcement on the tracking rating results of convertible corporate bonds
Asia Pacific Pharmaceutical: Anxin Securities Co., Ltd.'s listing sponsorship letter for the company's public offering of convertible corporate bonds
Asia Pacific Pharmaceuticals: Credit Rating Report on Publicly Issued Convertible Corporate Bonds
Asia Pacific Pharmaceutical: Letter of Sponsorship from Anxin Securities Co., Ltd. relating to the company's public offering of convertible corporate bonds
Asia Pacific Pharmaceutical: Guohao Lawyers (Hangzhou) Firm's Supplementary Legal Opinion on the Company's Public Issuance of Convertible Corporate Bonds (1)
Asia Pacific Pharmaceutical: Legal opinion of Guohao Law Firm (Hangzhou) on the company's public issuance of convertible corporate bonds
Asia Pacific Pharmaceuticals: Online Roadshow Announcement on Public Issuance of Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: Response to issues relating to the company's notification letter on the public offering of convertible corporate bonds
